Current Investments

Cleversafe Inc., the solution for limitless data storage recently announced breakthrough capabilities for combined storage and massive computation, being the first system to support storage and analysis of datasets at previously unattainable scale with unparalleled reliability and efficiency. Cleversafe’s object based storage system is 100 million times more reliable than traditional RAID-based systems. Its information dispersal capabilities reduce storage costs up to 90 percent while meeting compliance requirements and ensuring protection against data loss. Cleversafe’s customers include many major enterprise, government, medical, media, and other companies facing the most challenging big data issues at petabyte levels and beyond. Its investors include several of the top government and venture capital firms in the United States.

NextGen Solar LLC was co-founded by Len Batterson and Dr. Richard Brotzman, formerly part of the management team that developed Nanophase Technologies into a successful IPO, to develop an entirely new three-dimensional thin film solar cell and panel technology. Present-day solar panel technologies offer low to modest solar energy capture efficiencies and/or high manufacturing costs. NextGen Solar is developing a critically-needed breakthrough based on nanotechnology, to combine the best elements of inorganic semiconductors (high efficiency) with organic semiconductors (low cost non-toxic/earth-abundant materials and manufacturing) into one system, aiming to deliver 10% to 20% solar capture efficiency at a cost-of-goods sold of approximately $0.30/watt by the year 2015.

TSB is a Florida corporation that has acquired and is developing a novel topical antimicrobial technology. The technology allows for an unprecedented combination of safety, broad-spectrum antimicrobial efficacy against bacteria, viruses and fungi, and clinically significant persistence. Yet it is benign to the skin and the environment. The technology has already been proven safe and effective on humans via limited approvals in Europe.